Dealmaking in the pharma, medical and biotech (PMB) subsectors was driven by both old and new market trends in 2022 -
Following a ground-breaking year for dealmaking in 2021, global healthcare M&A remained robust in 2022,...more
1/25/2023
/ Acquisitions ,
Biotechnology ,
Cross-Border ,
Global Dealmaking ,
Healthcare ,
Investment ,
Investors ,
Mergers ,
Pharmaceutical Industry ,
Popular ,
Private Equity ,
UK